Bucher to Distribute Fluxion's Cell Analysis Tools in Switzerland | GenomeWeb
NEW YORK (GenomeWeb News) – Cellular analysis toolmaker Fluxion Biosciences said yesterday that it has hired Bucher Biotec to sell and distribute its research tools to drug developers in Switzerland.
 
Under the exclusive agreement, Basel-based Bucher will distribute Fluxion’s BioFlux cell imaging analysis tools.
 
The BioFlux 200 is used in cell adhesion and microbial biofilm studies and allows researchers to study live cells and biofilms under controlled conditions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.